Pharmacists will play a significant role in TKI adherence rates among patients.
Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.
Data have shown the potential for the therapy to treat several new conditions.
Understanding differences in the various levodopa formulations and assisting with medication therapy management is a crucial role for pharmacists.
This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Pharmacists are an important part of the care team for patients with bleeding disorders, providing services such as medication counseling and reconciliation.
A collaborative exercise with 16 health care organizations nets millions in savings.
Pharmacists should be aware of current discussions, attempted fixes, and expected length of drug shortages.
Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
The Covid-19 pandemic has elevated telehealth as a viable alternative to face-to-face interactions under certain circumstances, the list of which is expanding as technology expands and clinicians become more accustomed to and adept in its use.
Tapping techs as immunizers opens up greater visibility and new source of health care labor.
A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
The incidence of vancomycin-resistant enterococci has nearly doubled in recent years.
COVID-19 has increased the demand for new, safer curbside conveniences and the health care industry—including the pharmacy—has transformed rapidly to meet patient needs and prioritize safety as a result of the pandemic.
Drs Anthony Perissinotti and Kirollos Hanna provide some important considerations for pharmacists in treating chronic lymphocytic leukemia.
Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.
The disease is complex, but many opportunities exist for pharmacist intervention.
As pharmacy practice continues to evolve, it is imperative to recognize the vital contributions of all members of the pharmacy team, including pharmacy technicians.
As more becomes known about Crohn disease, treatment modalities have evolved with biologic monoclonal antibodies becoming a key part of guideline- and evidence-based medicine.
Person-centered care focuses on tailoring treatment plans, providing medication support, and ensuring access to resources that meet their unique needs.
For the management of ovarian cancer, it has been observed in both cellular and animal models that curcumin suppresses cell proliferation and promotes apoptosis.
Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
The use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.
Every pharmacist can make a difference in patients’ lives by taking the time to understand and fulfill the community’s social and cultural needs.
Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
Analyzing the patent and trademark challenges faced by 503A compounding pharmacies.
Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.
Precision oncology represents an evolution in therapeutic practice.